Citations (27)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Marwa El-Hussieny, Mansoura A. Abd-El-Maksoud, Fouad M. Soliman, Marwa A. Fouad & Mohamed K. El-Ashrey. (2023) Dual-target ligand discovery for Alzheimer’s disease: triphenylphosphoranylidene derivatives as inhibitors of acetylcholinesterase and β-amyloid aggregation. Journal of Enzyme Inhibition and Medicinal Chemistry 38:1.
Read now
Read now
Shenvi Kudchadker Gayatri, Vaishnavi Chhabra, Harish Kumar & M. Elizabeth Sobhia. (2023) Identification of prospective covalent inhibitors for SARS-CoV-2 main protease using structure-based approach. Journal of Biomolecular Structure and Dynamics 41:16, pages 7913-7930.
Read now
Read now
Sirasa Ruangritchankul, Prawat Chantharit, Sahaphume Srisuma & Leonard C Gray. (2021) Adverse Drug Reactions of Acetylcholinesterase Inhibitors in Older People Living with Dementia: A Comprehensive Literature Review. Therapeutics and Clinical Risk Management 17, pages 927-949.
Read now
Read now
Andrea Haake, Kevin Nguyen, Lauren Friedman, Binu Chakkamparambil & George T Grossberg. (2020) An update on the utility and safety of cholinesterase inhibitors for the treatment of Alzheimer’s disease. Expert Opinion on Drug Safety 19:2, pages 147-157.
Read now
Read now
Neelima Ayyalasomayajula & Challa Suresh. (2018) Mechanistic comparison of current pharmacological treatments and novel phytochemicals to target amyloid peptides in Alzheimer’s and neurodegenerative diseases. Nutritional Neuroscience 21:10, pages 682-694.
Read now
Read now
Articles from other publishers (22)
Syeda Khair-ul-Bariyah, Muhammad Sarfraz, Ahsan Sharif, Zahoor Hussain Farooqi, Muhammad Arshad, Ejaz Ahmed, Muhammad Ashraf, Shawana Abdullah, Muhammad Nadeem Arshad & Amir Waseem. (2024) Novel benzothiazole sulfonamides as potent α-glucosidase and cholinesterase inhibitors: Design, synthesis, structural properties, biological evaluation and docking studies. Journal of Molecular Structure 1299, pages 137118.
Crossref
Crossref
Gabbie E. Portlock, Matthew D. Smith, Eveline P. van Poelgeest & Tomas James Welsh. (2023) Therapeutic dilemmas: cognitive enhancers and risk of falling in older adults—a clinical review. European Geriatric Medicine 14:4, pages 721-732.
Crossref
Crossref
Tianhua Zhai, Emily Krass, Fangyuan Zhang & Zuyi Huang. (2023) A computational framework for identifying chemical compounds to bind Apolipoprotein E4 for Alzheimer’s disease intervention. Frontiers in Systems Biology 3.
Crossref
Crossref
S. Shahab, H. A. Almodarresiyeh, M. Sheikhi, Z. Ihnatovich & L. Filippovich. (2023) Density Functional Theory Investigation, Bioactivity, Absorption, Distribution, Metabolism, and Excretion Properties, Docking and in Silico Analysis of New Effective Piperazine Derivatives against Alzheimer’s Disease. Russian Journal of Physical Chemistry B 17:3, pages 725-737.
Crossref
Crossref
Bui Thanh Tung, Ta Thi Thu Hang, Nguyen Bao Kim, Nguyen Hong Nhung, Vu Khanh Linh & Dang Kim Thu. (2022)
Molecular docking and molecular dynamics approach to identify potential compounds in
Huperzia squarrosa
for treating Alzheimer’s disease
. Journal of Complementary and Integrative Medicine 19:4, pages 955-965.
Crossref
Crossref
Teresa Pardo-Moreno, Anabel González-Acedo, Antonio Rivas-Domínguez, Victoria García-Morales, Francisco Jose García-Cozar, Juan Jose Ramos-Rodríguez & Lucía Melguizo-Rodríguez. (2022) Therapeutic Approach to Alzheimer’s Disease: Current Treatments and New Perspectives. Pharmaceutics 14:6, pages 1117.
Crossref
Crossref
Adnan Ahmad & Krishan Pal. (2022) Therapeutic Efficacy of Natural Phytochemicals as Acetylcholinesterase Inhibitors Against Alzheimer’s Disease. Journal of Ecophysiology and Occupational Health 22:1, pages 39.
Crossref
Crossref
Gumpeny R. Sridhar. 2022. NeuroPsychopharmacotherapy. NeuroPsychopharmacotherapy
2709
2721
.
Muhammad Arshad, Kainat Ahmed, Maryam Bashir, Naveen Kosar, Maleeha Kanwal, Maqsood Ahmed, Hidayat Ullah Khan, Shahnaz Khan, Abdul Rauf, Amir Waseem & Tariq Mahmood. (2021) Synthesis, structural properties and potent bioactivities supported by molecular docking and DFT studies of new hydrazones derived from 5-chloroisatin and 2-thiophenecarboxaldehyde. Journal of Molecular Structure 1246, pages 131204.
Crossref
Crossref
Gabriella Marucci, Michela Buccioni, Diego Dal Ben, Catia Lambertucci, Rosaria Volpini & Francesco Amenta. (2021) Efficacy of acetylcholinesterase inhibitors in Alzheimer's disease. Neuropharmacology 190, pages 108352.
Crossref
Crossref
Da-Hua Shi, Meng-qiu Song, Xiao-Dong Ma, Jia-Bin Su, Jing Wang, Xiu-Jun Wang, Yu-Wei Liu, Wei-Wei Liu & Xin-Xin Si. (2020) Synthesis, characterization, crystal structures, and the biological evaluation of 2-phenylthiazole derivatives as cholinesterase inhibitors. Journal of Chemical Research 45:5-6, pages 572-581.
Crossref
Crossref
Sara Silva, António J. Almeida & Nuno Vale. (2021) Acetylcholinesterase inhibitors and nanoparticles on Alzheimer’s disease: a review. Journal of Nanoparticle Research 23:1.
Crossref
Crossref
Gumpeny R. Sridhar. 2020. NeuroPsychopharmacotherapy. NeuroPsychopharmacotherapy
1
13
.
Willian Orlando Castillo-Ordoñez & Nohelia Cajas-Salazar. 2020. Diagnosis and Management in Dementia. Diagnosis and Management in Dementia
631
645
.
Ehab Mahran, Ibrahim El Gamal, Michael Keusgen & Gertrud E. Morlock. (2019) Effect-directed analysis by high-performance thin-layer chromatography for bioactive metabolites tracking in Primula veris flower and Primula boveana leaf extracts. Journal of Chromatography A 1605, pages 460371.
Crossref
Crossref
Weicong Lin, Xiaojie Zheng, Danqing Fang, Shengfu Zhou, Wenjuan Wu & Kangcheng Zheng. (2018) Identifying hQC Inhibitors of Alzheimer’s Disease by Effective Customized Pharmacophore-Based Virtual Screening, Molecular Dynamic Simulation, and Binding Free Energy Analysis. Applied Biochemistry and Biotechnology 187:4, pages 1173-1192.
Crossref
Crossref
Björn Kruse, Sandra Verena Müller & Tanja Sappok. (2019) Demenz bei Menschen mit geistiger Behinderung. NeuroTransmitter 30:3, pages 36-45.
Crossref
Crossref
Rosa Maria Vitale, Vincenzo Rispoli, Doriana Desiderio, Roberta Sgammato, Stefano Thellung, Claudio Canale, Massimo Vassalli, Marianna Carbone, Maria Letizia Ciavatta, Ernesto Mollo, Vera Felicità, Rosaria Arcone, Margherita Gavagnin Capoggiani, Mariorosario Masullo, Tullio Florio & Pietro Amodeo. (2018)
In Silico
Identification and Experimental Validation of Novel Anti-Alzheimer’s Multitargeted Ligands from a Marine Source Featuring a “2-Aminoimidazole plus Aromatic Group” Scaffold
. ACS Chemical Neuroscience 9:6, pages 1290-1303.
Crossref
Crossref
Rita Khoury, Jayashree Rajamanickam & George T. Grossberg. (2018) An update on the safety of current therapies for Alzheimer’s disease: focus on rivastigmine. Therapeutic Advances in Drug Safety 9:3, pages 171-178.
Crossref
Crossref
Joyshree Biswas, Poonam Goswami, Sonam Gupta, Neeraj Joshi, Chandishwar Nath & Sarika Singh. (2015) Streptozotocin Induced Neurotoxicity Involves Alzheimer’s Related Pathological Markers: a Study on N2A Cells. Molecular Neurobiology 53:5, pages 2794-2806.
Crossref
Crossref
Kai Yang & Jin-Tao Liu. (2015) One-pot asymmetric reductive amination of ketones induced by polyfluoroalkanesulfinamide. Journal of Fluorine Chemistry 173, pages 18-22.
Crossref
Crossref
Ying Fu, Yanhua Liu, Yaojuan Chen, Helmut M. Hügel, Minzhu Wang, Danfeng Huang & Yulai Hu. (2012) Trimethylsilyl chloride promoted synthesis of α-branched amines by nucleophilic addition of organozinc halides to nitrones. Organic & Biomolecular Chemistry 10:38, pages 7669.
Crossref
Crossref